1.
Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, et al. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics [Internet]. 2017 May 1 [cited 2024 Jun. 26];72(5):317-24. Available from: https://journals.usp.br/clinics/article/view/133343